Page last updated: 2024-11-07

methylprednisolone acetate and Mouth Ulcer

methylprednisolone acetate has been researched along with Mouth Ulcer in 1 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Research Excerpts

ExcerptRelevanceReference
"We randomized 86 patients who had active disease with genital ulcers to receive either intramuscular corticosteroid injections (40 mg methylprednisolone acetate) or placebo every 3 weeks for 27 weeks."5.12A double-blind trial of depot corticosteroids in Behçet's syndrome. ( Fresko, I; Gogus, F; Mat, C; Ozyazgan, Y; Uysal, O; Uysal, S; Yazici, H; Yurdakul, S, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mat, C1
Yurdakul, S1
Uysal, S1
Gogus, F1
Ozyazgan, Y1
Uysal, O1
Fresko, I1
Yazici, H1

Trials

1 trial available for methylprednisolone acetate and Mouth Ulcer

ArticleYear
A double-blind trial of depot corticosteroids in Behçet's syndrome.
    Rheumatology (Oxford, England), 2006, Volume: 45, Issue:3

    Topics: Adolescent; Adult; Anti-Infective Agents; Behcet Syndrome; Delayed-Action Preparations; Double-Blind

2006